The association of out-of-hospital postpartum NSAID use and post-discharge hypertension control for people with hypertensive disorders of pregnancy

Pregnancy Hypertens. 2023 Sep:33:34-38. doi: 10.1016/j.preghy.2023.07.002. Epub 2023 Jul 18.

Abstract

Objective: To evaluate the relationship between amount of NSAID use postpartum and outpatient blood pressure (BP) control.

Study design: This is a prospective, single-site, cohort study of postpartum people diagnosed with HDP from 2018 to 2020 using the American College of Obstetrician and Gynecologists criteria. All participants were provided an electronic BP cuff for daily evaluation after discharge. Those who provided at least 7 days of data within the first 14 days after discharge were included. Standard PP pain management included ibuprofen 600 mg every 6 h as needed. The exposure was self-reported amount of NSAIDs used within the first 14 days after discharge. The primary outcome was median mean arterial pressure (MAP) over the first 14 days after hospital discharge. Secondary outcomes included median and maximum systolic and diastolic BPs and need for PP readmission for HDP. Regression models were created, controlling for a propensity score for highest quartile of NSAID use.

Results: 103 participants were approached, of whom 60 met inclusion criteria. Those who had a history of a cesarean delivery were more likely to be in the highest quartile of NSAID use; no other significant differences were noted across quartiles of NSAID use. There was no association between NSAID amount used and median MAP (adjusted β coefficient 0.03, 95% CI: -0.17 to 0.22). There were no significant associations between NSAID amount used and all other secondary outcomes.

Conclusion: Out-of-hospital NSAID use is not associated with worsened PP BP control after hospital discharge among people diagnosed with HDP.

Keywords: Hypertensive disorders of pregnancy; Non-steroidal anti-inflammatory drugs; Postpartum; Preeclampsia.

MeSH terms

  • Aftercare
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cohort Studies
  • Female
  • Hospitals
  • Humans
  • Hypertension, Pregnancy-Induced* / drug therapy
  • Patient Discharge
  • Postpartum Period
  • Pre-Eclampsia*
  • Pregnancy
  • Prospective Studies

Substances

  • Anti-Inflammatory Agents, Non-Steroidal